Genmab — Marts 2019
-
Jeg har fået det indtryk at det kun er første arm, der skal bruges i første omgang https://clinicaltrials.gov/ct2/show/NCT03412565?term=Mmy-2040&rank=1
-
In order to obtain a broader label, we would also need to obtain safety data from the PLEIADES study which is evaluating 3 cohorts of patients DARA + R
D, DARA + VMP and DARA + VRD. If this study reads out positively, we expect to obtain a broad label for SC DARA.. -
Spændende billede, hvor det er sjovt at kigge nærmere på navnene på stjernerne. https://www.google.com/search?client=ms-unknown&q=Plejaderne&stick=H4sIAAAAAAAAAONgFuLUz9U3MK8oNytX4gAx03KLU7TEnVNzUotLMhNz_JOyUpNLgjNTUssTK4sXsXIF5KRmJaakFuWlAgAtB_OrPQAAAA&sa=X&ved=2ahUKEwiIsrup_-jgAhXSzaYKHYuMD1gQxA0wCXoECAwQEg&biw=412&bih=735&dpr=2.63#imgdii=URpDb6TKJgeRuM:&imgrc=cVKnlYHwrPj6zM:
-
https://clinicaltrials.gov/ct2/history/NCT03412565?A=6&B=16&C=Side-by-Side#StudyPageTop Sep 19 til april 20 betød Kyprolis udvidelsen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind